MINI FUTURE LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Borsa Italiana 12:04:47 05/06/2024 am IST | ||
| 5.09 EUR | +0.99% |
|
| Current month | -9.21% | ||
| 1 month | -33.20% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 5.09 | +0.99% |
| 03/24/03 | 5.04 | -7.18% |
| 31/24/31 | 5.43 | +26.28% |
| 30/24/30 | 4.3 | -5.08% |
| 29/24/29 | 4.53 | -7.93% |
Real-time Borsa Italiana
Last update June 05, 2024 at 12:04 am IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
BNP Paribas
|
| P1XU17 | |
| ISIN | NLBNPIT1XU17 |
| Date issued | 18/12/2023 |
| Strike | 43.49 € |
| Maturity | 20/12/2035 (4216 Days) |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.25 € |
|---|---|
| Lowest since issue | 3.88 € |
| Spread | 0.6 € |
| Spread % | 11.34% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.36
EUR
Average target price
52.64
EUR
Spread / Average Target
+8.85%
- Stock Market
- Certificates
- P1XU17 Certificat
